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ARTICLE
Blood stem cell-forming haemogenic endothelium
in zebraﬁsh derives from arterial endothelium
Florian Bonkhofer1, Rossella Rispoli1,2,5, Philip Pinheiro1,5, Monika Krecsmarik1,3, Janina Schneider-Swales1,
Ingrid Ho Ching Tsang1, Marella de Bruijn1, Rui Monteiro 1,3,4, Tessa Peterkin1 & Roger Patient1,3
Haematopoietic stem cells are generated from the haemogenic endothelium (HE) located in
the ﬂoor of the dorsal aorta (DA). Despite being integral to arteries, it is controversial
whether HE and arterial endothelium share a common lineage. Here, we present a transgenic
zebraﬁsh runx1 reporter line to isolate HE and aortic roof endothelium (ARE)s, excluding non-
aortic endothelium. Transcriptomic analysis of these populations identiﬁes Runx1-regulated
genes and shows that HE initially expresses arterial markers at similar levels to ARE.
Furthermore, runx1 expression depends on prior arterial programming by the Notch ligand
dll4. Runx1−/− mutants fail to downregulate arterial genes in the HE, which remains inte-
grated within the DA, suggesting that Runx1 represses the pre-existing arterial programme in
HE to allow progression towards the haematopoietic fate. These ﬁndings strongly suggest
that, in zebraﬁsh, aortic endothelium is a precursor to HE, with potential implications for
pluripotent stem cell differentiation protocols for the generation of transplantable HSCs.
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Deﬁnitive haematopoietic stem cells (HSCs) drive lifelongreconstitution of the blood system and are pivotal in thetreatment of haematological disorders including leukae-
mia1. During embryogenesis, HSCs are generated from an endo-
thelial precursor termed haemogenic endothelium (HE)2–5.
Replication of this process will facilitate the generation of trans-
plantable HSCs in vitro from pluripotent stem cells (PSCs).
However, despite recent advances in generating blood progenitors
with broad potential6, the in vitro generation of transplantable
HSCs without genetic manipulation has yet to be reported7,8.
This likely reﬂects the complexity of embryonic haematopoiesis
occurring in multiple tissues with differing genetic programmes1,9.
The mouse embryo harbours at least two types of HE, in the extra-
embryonic yolk sac (YS) and the embryo proper10. HE with the
potential to give rise to HSCs is found mainly in the ﬂoor of the
dorsal aorta (DA)11, but whether HE derives from arterial endo-
thelium or represents an independent lineage is controversial12–14.
The transcription factor Runx1 is expressed in HE and is
essential for the emergence of HSCs15,16. Runx1 is required for
the endothelial to haematopoietic transition (EHT)17,18, leading
to the formation of intra-aortic clusters (IAC) containing HSCs19.
Mechanistically, Runx1 facilitates EHT by repressing the endo-
thelial programme through upregulation of the transcriptional
repressors, Gﬁ1/Gﬁ1b18. However, Runx1 was shown to still be
required for HSC formation even after most HE cells have dif-
ferentiated into IAC cells, indicating that RUNX1 regulates as yet
unknown, critical target genes20.
Here, we present a detailed in vivo analysis of the aortic HE
based on a newly generated zebraﬁsh runx1 reporter line. In
addition to the identiﬁcation of HE-speciﬁc Runx1-activated
genes, we show that arterial gene expression in the HE is nega-
tively regulated by Runx1. HE not only maintains an arterial
programme in runx1−/− mutants, but it is also dependent on
prior arterial speciﬁcation, strongly suggesting that HE derives
from aortic endothelium.
Results
A TgBAC(runx1P2:Citrine) reporter labels aortic HE. To
characterize the aortic HE and to screen for Runx1 targets, we
utilized the zebraﬁsh model. Here, the runx1 gene structure is
largely conserved, including regulation by two alternative pro-
moters, P1 and P2 (Fig. 1a). However, in zebraﬁsh, exon 2 is split
into 2a and 2b by a non-conserved intron, positioned where mice/
humans harbour an in-exon splice site (Fig. 1a and Supplemen-
tary Fig. 1a). Isoform-speciﬁc in situ hybridization (ISH) shows
that runx1 expression in the HE is solely initiated through P2
activity (Fig. 1b, c). To ensure proper regulation in runx1 reporter
ﬁsh, we made use of bacterial artiﬁcial chromosome (BAC)
technology. Of the four previously identiﬁed zebraﬁsh BACs
containing runx121, we chose the 97a02 BAC which harbours
both promoters plus substantial upstream sequence (Supple-
mentary Fig. 1b). A Citrine cassette followed by a polyA stop
signal was recombineered downstream of the P2 ATG (Fig. 1d) to
establish a stable TgBAC(runx1P2:Citrine) line, which expresses
Citrine under the control of runx1 regulatory elements.
During early haematopoietic development, Citrine expression
recapitulated endogenous runx1 in the posterior lateral meso-
derm (PLM) which contains precursors to endothelium and
primitive blood cells, but lacked expression in runx1+ Rohon-
Beard neurons (RBN) (Fig. 1e). Notably, Citrine transcripts were
detectable at least 1–2 h before endogenous runx1 (Supplemen-
tary Fig. 1c), likely caused by a shorter transcription cycle. This
allowed time for strong Citrine ﬂuorescence to be detected in the
migrating PLM from around 12–13 hpf (Supplementary Fig. 1d),
coincidental with the detection of runx1 expression by ISH.
During the subsequent deﬁnitive haematopoiesis, runx1 is ﬁrst
detectable in the aortic HE by ISH from ~23/24 hpf onwards22.
Importantly, Citrine RNA was detectable in the HE at 24 hpf
(Fig. 1f), Citrine ﬂuorescence mimicked expression of runx1
(Fig. 1g, h) and no difference in runx1 expression was detectable
between reporter and wild-type embryos (Supplementary Fig. 1e).
Unlike the earlier Rohon-Beard neurons, Runx1+ spinal cord
neurons also expressed Citrine, suggesting that some neuronal
enhancers are included in the BAC construct. Around 50 hpf,
when most HE cells had initiated EHT2, Citrine+ cells were found
in the sub-aortic space (Supplementary Fig. 1f) and in the caudal
haematopoietic tissue (CHT) (Fig. 1i), with the kdrl:mCherry
transgene delineating the endothelial domain. Over subsequent
days, Citrine+ cells were detectable within all haematopoietic
niches including the CHT, the thymus and the kidney
(Supplementary Fig. 1g). Morpholino (MO) knock-down of the
upstream regulators, tal1b and gata2b23,24, further validated
proper regulation of the BAC-driven runx1P2:Citrine transgene
for haematopoietic tissues (Supplementary Fig. 1h). Overall, we
present a runx1 reporter line suitable for the analysis of aortic HE
in vivo.
Isolation of enriched haemogenic and aortic roof endothelium.
To analyse the DA region in more detail we used TgBAC
(runx1P2:Citrine);Tg(kdrl:mCherry) double-transgenic embryos
(Fig. 2a) at 29 hpf. Co-presence of mCherry in Citrine+ cells of
the DA lining conﬁrmed their endothelial identity (Fig. 2b).
Unexpectedly, we detected additional weak Citrine ﬂuorescence
in the aortic roof endothelium (ARE) and sprouting inter-somitic
vessels (ISV), but not in non-aortic endothelium (NAE) including
the cardinal vein (CV) and veins and arteries in the head and tail.
Immunohistochemistry conﬁrmed the presence of stable Citrine
protein in the ARE, whereas RNA expression was only detectable
in the DA ﬂoor (Supplementary Fig. 2a). The weak Citrine
ﬂuorescence in ARE diminished over the next ~24 hours (Sup-
plementary Fig. 2b) indicating high protein stability, also seen in
primitive erythrocytes (eryP) (Supplementary Fig. 2c). These
ﬁndings indicate a carryover of residual Citrine protein to the
ARE from earlier stages of DA development and suggest a lineage
relationship between runx1+ and runx1− aortic endothelium.
Next, we analysed Citrine transgene expression during DA
lumenisation at 18–22 hpf. Fluorescent ISH (FISH) highlighted
that runx1 is expressed at 22 hpf (Supplementary Fig. 2d) with the
ﬁrst positive cell detectable at 20 hpf. Importantly, we also detect
Citrine RNA expression already at 18–20 hpf and Citrine
ﬂuorescence from ~20 hpf onwards in most DA cells, before
expression became restricted to the DA-ﬂoor (Supplementary
Fig. 2e–g), likely being the cause of the carryover of Citrine
protein detected in the ARE (Fig. 2b). We propose that DA
angioblasts, upon reaching the midline and just before lumenisa-
tion, experience the ﬁrst runx1 inductive signals, including
BMP25, detected by our runx1P2:Citrine reporter. As a con-
sequence of lumenisation, cells in the ﬂoor of the DA will stay
proximal to the ventral BMP source and continue to upregulate
the Citrine reporter, as well as endogenous runx1 to levels
detectable by ISH, while cells in the roof are positioned distal to
the BMP source and lose expression of Citrine and runx1.
To isolate the HE, here operationally deﬁned as runx1+
endothelium of the DA-ﬂoor, a FACS gating strategy was
established (Fig. 2c). runx1P2:Citrine+kdrl:mCherry+ double
positive cells with high runx1P2:Citrine expression (DP-R1hi)
were discriminated from cells with lower Citrine intensity (DP-
R1med and DP-R1lo). Cells single-positive for kdrl:mCherry+
(SP-kdrl), representing a mixture of venous and arterial cells,
served as a NAE control. Molecular characterisation at 29 hpf
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(Fig. 2d) detected high expression of tal1 in DP-R1med and DP-
R1hi cells, while expression of the HE marker genes cmyb and
gﬁ1aa were exclusive to the DP-R1hi population. In contrast,
expression of the DA-roof marker, tbx20, was depleted from DP-
R1hi cells. Arterial marker genes efnb2a and dll4 were gradually
lost with increasing intensity of Citrine ﬂuorescence, in agree-
ment with a previously described early loss of endothelial
potential in HE that coincided with Runx1 expression26. Notably,
dll4 showed highest expression in the DP-R1lo population,
reﬂecting its arterial identity.
Quantiﬁcation of ﬂow-sorted populations detected 18.2 (+/−
3.0) DP-R1hi cells per embryo (Supplementary Fig. 3a–c),
representing ~1/5 (21.2% +/− 2.7) of the whole DA (including
ISV). These counts agree with previous estimates, including those
showing that the DA circumference consists of no more than 4
cells2 with ISV sprouts (2–4 cells) found every 2–3 aortic cells.
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Fig. 1 Generation of a zebraﬁsh BAC transgenic reporter line for runx1. a Schematic representation of the zebraﬁsh runx1 locus. Exon nomenclature adjusted
to the human RUNX1 locus. P1 and P2 indicate the distal and the proximal promoter respectively (TSS: transcriptional start site). b Schematics of the two
alternative transcripts derived from the alternative promoters P1 and P2. Transcript-speciﬁc and pan binding ISH probes are indicated with their respective
lengths. c ISH for runx1 isoforms in 30 hpf embryos. Left panel: trunk region. Right panel: head region. Green arrows point to the HE, yellow arrows show the
olfactory placode and purple arrows depict neurons in the brain region. d Schematic of the recombineered 97a02 BAC. A Citrine reporter cassette was
placed downstream of the P2 ATG. e Confocal microscopy image of a ﬂat mounted 15 hpf embryo after double FISH for runx1 and Citrine in TgBAC(runx1P2:
Citrine) depicting the region of the posterior lateral plate mesoderm (PLM) and Rohon-Beard neurons (RBN). Maximum intensity projection of a 58 µm
stack. f–h Gene expression analysis for runx1 and runx1P2:Citrine during deﬁnitive haematopoiesis. Green arrows point to the HE. Yellow arrowheads point to
neurons in the spinal cord. f ISH for runx1 or Citrine in 24 hpf TgBAC(runx1P2:Citrine) embryos. g ISH for runx1 in 30 hpf embryos. h Representative
ﬂuorescent microscopy image of a 31 hpf TgBAC(runx1P2:Citrine) embryo. Insets in (g and h) enlarge the boxed region. i Fluorescent microscopy image of a
50 hpf double transgenic TgBAC(runx1P2:Citrine);Tg(kdrl:mCherry) embryo focusing on the region of the caudal haematopoietic tissue (CHT)
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Considering that most if not all DA ﬂoor cells are haemogenic2,
the ratio we detected (1/5 DP-R1hi to all DP cells) reﬂects the
reported DA composition.
Altogether, the combination of confocal microscopy, gene
expression analysis and ﬂow cytometric counting strongly
suggests that DP-R1hi cells represent the aortic HE, while DP-
R1lo cells represent the ARE (Fig. 2e). Overall, our strategy
successfully discriminated between HE and ARE while simulta-
neously excluding NAE.
Early repression of the endothelial programme in aortic HE.
For further characterisation of the deﬁned endothelial popula-
tions we performed RNA-seq analysis at 29 hpf (Fig. 3a, b), ~5 h
after runx1 becomes detectable by ISH and shortly before EHT.
The number of mapped reads of runx1 and Citrine as well as of
kdrl and mCherry were well correlated (Supplementary Fig. 4a).
Transcripts per million (TPM) values for the haemogenic genes
tal1, cmyb and gﬁ1aa, tracked the gene expression patterns as
detected by qPCR (Supplementary Figs. 4b and 2d). Expression of
the arterial markers dlc, vegfc, dll4 and hey2 was enriched in
SP-kdrl, DP-R1lo and DP-R1med populations and depleted in the
DP-R1hi. As expected, nr2f2 expression was only enriched in the
SP-kdrl population (Supplementary Fig. 4c). The low TPM values
for myod1, pdgfra and cdh17 suggest only minimal contamination
by cells of the myotome, sclerotome/neural crest or pronephros,
respectively, mostly within the SP-kdrl population.
Multidimensional scaling (MDS) analysis demonstrated that
biological replicates clustered together and placed the HE further
from the NAE than from the ARE populations on the ﬁrst
dimension (Fig. 3c). We found 5213 differentially expressed genes
(DEG) (log2-FC <+/− 0.7) across all populations (one-way
ANOVA, FDR < 0.05) (Supplementary Data 1). Consensus
clustering analysis (Supplementary Fig. 5a–c) further supported
the endothelial character of DP-R1lo cells that shared a substantial
gene set with endothelial cells of the SP-kdrl gate (Cluster 1, 2570
genes). DP-R1lo cells also possessed a unique programme (Cluster
4, 242 genes) containing the arterial markers dll4 and hey2. In
agreement with the MDS plot analysis, DP-R1hi cells shared a
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larger genetic programme with DP-R1lo/DP-R1med cells (Cluster
2, 1305 genes) than with SP-kdrl cells (Cluster 5, 812 genes). In
line with the detected carryover of Citrine protein to the ARE,
these genetic commonalities hint at a close lineage relationship
between the HE and ARE.
While most HE markers, cmyb, gata2b and gﬁ1aa23,27,28 were
part of Cluster 2, the previously identiﬁed HE-speciﬁc gene
dnmt3bb.129 was not. To identify the most meaningful set of HE-
speciﬁc genes we performed DEG analysis between the closely
related HE (DP-R1hi) and ARE (DP-R1lo) (Fig. 3d, e), while
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excluding the mixed population of NAE (SP-kdrl). Overall, 2731
DEGs were identiﬁed (Supplementary data 2) of which 1099
genes were HE-speciﬁc (upregulated in DP-R1hi). All known HE-
marker genes were found within a subset of 131 genes with a
log2-FC > 1.7 (Fig. 3e). HE-speciﬁc genes were enriched for gene
ontology (GO) terms associated with cellular and metabolic
processes (Fig. 3f), suggesting that the HE is in an active
metabolic state, possibly adjusting its core machinery while
transitioning from an endothelial to a haematopoietic identity. In
contrast, within the 1633 ARE-speciﬁc genes (downregulated in
DP-R1hi) many endothelial and arterial genes were found
(Fig. 3e). The ARE-speciﬁc genes were enriched for GO terms
related to angiogenesis and vessel development (Fig. 3f), in turn
indicating an early genome wide repression of the endothelial
programme within the HE. Likewise, the top enriched KEGG
pathway for ARE-speciﬁc genes was “Notch signalling pathway”
(Supplementary Fig. 5d), agreeing with recent studies showing a
repression of Notch signalling in the HE during the EHT and
further haematopoietic development30–32.
We further performed ATAC-seq analysis to study the open
chromatin in DP-R1lo and DP-R1hi populations (Supplementary
Fig. 5e, f). Overall, we identiﬁed 3865 peaks unique for the HE
(DP-R1hi) and 5603 peaks speciﬁc for the ARE (DP-R1lo) (Fig. 3g;
Supplementary Data 3). De novo motif analysis identiﬁed ETS
binding motifs as the top enriched motive for both ARE and HE,
reﬂecting their endothelial identity. ARE-speciﬁc peaks were also
enriched for the Gﬁ1b binding motif, in agreement with the
previously described Runx1-Gﬁ1 axis repressing endothelial
genes18 (Fig. 3h). Strikingly, HE-speciﬁc peaks were strongly
enriched for the RUNX motif, implying a broad input for Runx1
required for HE progression to blood progenitors.
Identiﬁcation of HE-speciﬁc Runx1-regulated genes. To iden-
tify Runx1-regulated genes, perturbation experiments were per-
formed using a well-established runx1 splice MO2,22 that
phenocopies the runx1−/− mutant33 (Supplementary Fig. 6a,b).
TgBAC(runx1P2:Citrine) morphants showed a loss of Citrine+
cells in the CHT at 56 hpf. In contrast, the HE was widely
unaffected at 35 hpf, in line with Runx1 being dispensable for
establishing HE18, thus allowing FACS-based isolation for sub-
sequent RNA-seq analysis to identify Runx1 targets.
DEG analysis was performed between DP-R1hi populations of
runx1 MO and control conditions, as well as between the double-
negative (DN) populations to correct for MO off-target effects
(Fig. 4a). MDS plot analysis showed that DP-R1hi replicates
clustered according to the presence/absence of the MO, while DN
replicates all clustered together (Fig. 4b). Overall, we identiﬁed
676 DEG for the DP-R1hi population and only 176 DEG for DN
cells (Supplementary Fig. 6c). Genes that correlated positively in
both analyses were considered as off-targets and eliminated from
the analysis (Supplementary Fig. 5d). Finally, we identiﬁed 245
Runx1-activated (MO-down) and 389 Runx1-repressed (MO-up)
genes (Supplementary data 4). Strikingly, we found the ARE
phenotype to be repressed to a substantial extent by Runx1
(Fig. 4c).
To identify the most meaningful targets involved in deﬁnitive
haematopoiesis we focused on 85 genes that were Runx1-
activated and HE-speciﬁc (Fig. 4d). Of those, 22 genes showed
evolutionarily conserved expression during the transition from
murine HE to HSPCs34,35 (Supplementary Table 1). Potential for
direct Runx1 binding was shown for 16 of those genes by ChIP-
seq in two haematopoietic cell lines, HCP7 and Kasumi-136–38.
We further analysed expression of the identiﬁed potential Runx1
targets in runx1−/− mutants39 using the BioMark platform
(Fig. 4e). We crossed the kdrl:mCherry and runx1P2:Citrine
reporter lines onto a homozygous runx1−/− background and
isolated the different subsets of the DA (Supplementary Fig. 7a).
Gene expression was analysed at three time-points to additionally
shed light on expression dynamics (Fig. 4f). For 11 of the 16 genes
expression levels were shown to increase over time speciﬁcally in
the HE and to be dependent on the presence of Runx1, also
conﬁrmed by ISH when functional probes were available (Fig. 4g;
Supplementary Fig. 7b). These genes include ﬁve of the six
zebraﬁsh dnmt3 isoforms, including dnmt3bb.1, previously
shown to be crucial for deﬁnitive haematopoiesis29. Other genes
are the transcriptional repressor gﬁ1ab, the haematopoietic genes
syk, irf1b and pik3cd, and the potential later niche genes angpt1
and mpl, both expressed in adult HSCs and downregulated in
Runx1−/− mutants40–43.
Overall, the identiﬁcation of HE-speciﬁc genes demonstrates
that our experimental setup is a powerful tool to analyse gene
expression dynamics within the HE and ARE. In combination
with a runx1−/− mutant background we further identiﬁed several
Runx1 targets for developmental haematopoiesis.
Initial dll4 expression in HE becomes repressed by Runx1.
Next, we used our experimental strategy dissecting HE from ARE
to analyse the expression of additional factors involved in HSC
development. Different ratios between Dll4- and Jag1-mediated
Notch signalling deﬁne the arterial and haemogenic fates44,
whereby Jag1 is needed for HSC speciﬁcation and a high Dll4 to
Jag1 ratio drives the arterial programme44–47. We therefore
analysed expression of dll4 and jag1a in the zebraﬁsh DA. In
agreement with another study47, highest expression of jag1a was
detected in SP-kdrl cells (up to 4.2-fold higher compared to DP-
R1hi/DP-R1lo), while a previously unidentiﬁed uniform expres-
sion was seen in the DA across the ARE and the HE (Fig. 5a). In
contrast, dll4 expression was dynamically regulated with an initial
uniform expression in all fractions and an HE-speciﬁc down-
regulation over time (Fig. 5b). In contrast, runx1−/− mutants
expressed dll4 at similar levels in the HE and the ARE at all
analysed timepoints. ISH also showed a downregulation of dll4 in
the ventral DA from 27 hpf onwards (Supplementary Fig. 8a), but
not in runx1 morphants (Supplementary Fig. 8b) or runx1−/−
Fig. 3 Characterization of genome wide gene expression in aortic HE. a Timeline depicting the most important events during deﬁnitive haematopoiesis in
the zebraﬁsh DA. At 29 hpf (red circle) cells of the HE have not yet initiated EHT but have been expressing runx1 for several hours. b Experimental scheme
to study HE and other endothelial sub-fractions by RNA-seq. Double transgenic TgBAC(runx1P2:Citrine);Tg(kdrl:mCherry) embryos were staged up to 28–30
hpf and taken forward for FACS based isolation of the indicated cell populations. RNA was isolated from at least 3,000 cells. n= 3 experiments have been
performed. c Multidimensional scaling plot (MDS-plot) analysis of the cell populations depicted in (b). d Experimental strategy to identify HE-speciﬁc
genes by comparing gene expression between HE (DP-R1hi) and ARE (DP-R1lo). e Left: Smear plot of the differentially expressed genes (DEGs) between
DP-R1hi and DP-R1lo. The number of signiﬁcantly enriched genes for each population is indicated. Right: Number of signiﬁcantly enriched genes with a log2-
FC >+/− 1.7. Selected haematopoietic (green) and endothelial (orange) genes are shown. f GO term analysis on HE-speciﬁc (green) and ARE-speciﬁc
(orange) gene-sets. Shown are the top 10 enriched terms (dark colour) plus additional informative terms (light colour). Haematopoietic and blood vessel
development related terms are highlighted in red. g Heat map showing differentially open peaks between DP-R1lo and DP-R1hi cells as identiﬁed by ATAC-
seq analysis. Genomic distribution of peaks is indicated. h de novo motif analysis underlying unique DP-R1lo or DP-R1hi speciﬁc peaks as indicated in (g)
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mutants (Fig. 5c). Importantly, double FISH showed co-
localisation of dll4 expression in regions of the HE also expres-
sing high levels of runx1 only in runx1−/− mutants but not in
WT embryos (Fig. 5d). These ﬁndings suggest that zebraﬁsh HE
is derived from a dll4+ progenitor and that dll4 repression in the
HE is Runx1-dependent.
Direct binding of Runx1 to the Dll4 gene locus was found in
previous ChIP-seq studies36,38. However, a likely candidate for an
indirect regulatory link is Sox17, shown to directly regulate
transcriptional activation of Dll4 in endothelial cells48. Our RNA-
seq analysis identiﬁed sox17 and the related sox32 as HE-speciﬁc
but Runx1-repressed genes. This was further validated in
runx1−/− mutants (Fig. 5e, f; Supplementary Fig. 8c), thus
providing the ﬁrst functional in vivo data on sox17 repression in
the HE. Direct RUNX1 binding to Sox17 has been reported
previously during haematopoietic differentiation in culture49.
Together, our ﬁndings suggest a model in which different Jag1 to
Dll4 ratios are established by a Runx1-dependent downregulation
of dll4 expression in the HE, either directly or indirectly via
repression of sox17 (Supplementary Fig. 8d).
HE of runx1−/− mutants maintains an arterial identity. The
arterial marker EfnB2 distinguishes arterial from venous endo-
thelium before functional distinctions are recognisable50.
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Fig. 4 Identiﬁcation of Runx1-regulated genes within the aortic HE. a Experimental scheme to identify Runx1-regulated genes in the HE (DP-R1hi).
Highlighted cell populations (DP-R1hi and DN) from un-injected (control) and runx1 MO-injected double transgenic TgBAC(runx1P2:Citrine);Tg(kdrl:mCherry)
embryos (28–30 hpf) were used for differential gene expression analysis (DEG) by RNA-seq similar to Fig. 3. b Multidimensional scaling plot (MDS-plot)
analysis of the cell populations depicted in (a). c Gene list intersection between ARE-speciﬁc and Runx1-repressed genes. d Gene list intersection between
HE-speciﬁc and Runx1-activated genes. e Experimental strategy to analyse potential HE-speciﬁc Runx1 target genes by qRT-PCR in runx1+/+ (WT) and
runx1−/− mutant (MUT) embryos. f Timeline highlighting the time-points (red circles) used for subsequent qRT-PCR analysis. g qRT-PCR gene expression
analysis of potential Runx1 targets (dnmt3ba, angpt1, irf1b and pik3cd) in the HE and ARE of runx1+/+ (WT) and the HE of runx1−/− mutant (MUT) embryos
at the time-points depicted in (f). Graphs show the mean of detected expression levels relative to the geometric mean (GM) of the two housekeeping
genes eef1a1l and rpl13a. n= 5 independent biological experiments for WT embryos and n= 6 independent biological experiments for MUT embryos. Error
bars represent the SEM. 2-way ANOVA; *p < 0.05; **p < 0.01; ***p < 0.001. h ISH analysis for the same genes analysed in (g) performed in runx1+/+ and
runx1−/− embryos
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Similarly to dll4 and sox17, expression of efnb2a was increased
within the HE of runx1−/− mutants, whereas expression of the
venous marker ephb4b was unchanged and generally low
(Fig. 6a). This prompted us to analyse expression of further
arterial and venous markers in our RNA-seq data. Strikingly,
arterial genes were generally upregulated in the HE of runx1
morphants, whereas venous genes were unaffected (Fig. 6b). HE
not only retained an arterial programme in the absence of Runx1
but also remained integrated into the DA lining, as detected by
runx1 expression or Citrine ﬂuorescence (Supplementary Fig. 9a),
even at 6 dpf (Fig. 6c, d).
To determine whether arterial identity is a prerequisite for
aortic HE, we analysed MO-mediated repression of dll4 and
indeed found a loss of runx1 expression (Fig. 6e), as well as of
cmyb that could be rescued by overexpressing runx1 in dll4
morphants (Supplementary Fig. 9b), while endothelial integrity
was unaffected (Supplementary Fig. 9c). Consistent with these
data, dll4−/− mutants also showed loss of runx1 expression in HE
(Fig. 6f). Similarly, Dll4−/− mice were reported to lack Runx1
expression in the HE at E9.5 but could not be investigated at later
stages due to early lethality45. Of note, knock-down of the arterial
gene cldn5b also resulted in a loss of runx1 (Supplementary
Fig. 9d), further suggesting that the arterial identity is required
beyond simply the Notch input. In agreement with our
observations in runx1−/− mutants, dll4 expression was increased
in those cldn5b-deﬁcient embryos. Together, these data suggest a
model in which aortic HE is derived from a Dll4+ Cldn5b+
arterial progenitor population (Fig. 6g), consistent with our
observation that initially most aortic cells hold the potential to
upregulate runx1P2:Citrine expression (Supplementary Fig. 2g,h).
Subsequent lumenisation creates the geometry for a signalling
gradient, whereby ARE stays arterial and the DA ﬂoor commits to
the haemogenic lineage25. The upregulation of Runx1 then leads
to the repression of arterial genes, allowing further differentiation
towards the haematopoietic fate.
Discussion
Two recent publications have concluded that HE is a distinct
lineage from aortic endothelium12,13. However, neither paper was
looking at the HE of the DA: one was studying yolk sac HE and
the other HE differentiated from PSCs. Here, making use of a
newly generated transgenic zebraﬁsh line, we have proﬁled HE
from the DA and compared it to the endothelium of the aortic
roof. We ﬁnd that while at earlier stages of development the gene
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expression proﬁles are very similar, HE and ARE eventually
become distinct. We further ﬁnd that the transition is mediated
by Runx1 and that, if Runx1 is inactivated, the cells that would
have formed HE retain the proﬁle of ARE, remaining in the aortic
endothelium and failing to undergo EHT. We show that Runx1 is
indeed acting on dll4+ cells, the main marker for the non-
haemogenic endothelium in the PSC study13, by observing co-
localisation of transcripts to individual DA ﬂoor cells before dll4
is silenced.
The HE-speciﬁc repression of dll4 by Runx1 additionally sug-
gests how high Jag1/Dll4 ratios are established in the zebraﬁsh
DA mediating low Notch1 signalling to the HE (Supplementary
Fig. 5d) as detected by Gama-Norton et al.44 in mouse. While in
the Gama-Norton et al. study the sensor for strong
Notch1 signalling depicted activity only in the endothelium that
is distinct from HSC precursors44, we speculate that, as in zeb-
raﬁsh, murine HE and aortic endothelium share a common
precursor initially experiencing high Notch1 signalling through
Dll4. Since the respective sensor in the Gama-Norton et al. study
was induced at E10.5 and thus ~24 h after Runx1 expression is
detectable44, together with the repression of Dll4 by Runx1 that
we have identiﬁed, our proposed model of a common lineage is in
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agreement with those observations. Furthermore, by inactivating
a representative arterial gene, dll4, we show that the arterial state
is a necessary prerequisite for HE formation in vivo. Indications
of a Runx1 dependence on Dll4 have also been reported in mice,
along with Gata245, and HE dependence on the arterial pro-
gramme has also been suggested using EphrinB2−/− mutants51.
Together with the here presented imaging and gene expression
data, this provides strong support for intra-embryonic HE being
derived from arterial angioblasts. Lastly, a necessity for the
repression of arterial identity genes, e.g. Sox17 and Notch1, was
shown for the endothelial to hematopoietic fate switch in the
mouse DA14. Here, we show that the repression of the arterial
programme is Runx1 driven, even though it remains to be clar-
iﬁed whether this repression is direct or indirectly regulated.
We propose that vascular endothelial progenitors, that sepa-
rated from the primitive blood precursors in the posterior lateral
plate mesoderm52,53, become committed to a DA fate at around
13–15 hpf in zebraﬁsh54,55 in the absence of a distinction between
future roof and ﬂoor cell fates. These precursors migrate to the
midline and form a cord which starts to lumenise from 18 hpf56.
It remains to be determined at which time point HE diverges
from the arterial lineage. Runx1 is initially not required for HE
differentiation as expression of a non-functional Runx1-LacZ
reporter gene is initiated normally in the ﬂoor of the mouse DA57,
and haemogenic competence can already be detected in murine
23GFP+ cells before Runx1 is expressed58. Similarly, expression
of haemogenic gata2b in the zebraﬁsh DA can be detected already
around 18–20 hpf23, and it is suggested that HSC fate is partly
established around 15–16 hpf during axial migration of DA pre-
cursors59, after the arterial and venous fate decision54. Sub-
sequent DA cord lumenisation results in the ﬂoor of the DA
remaining proximal to inductive BMP signals and distal to
Hedgehog signalling, which leads to haematopoietic gene
expression, starting with gata2b and runx123,25, while the roof
cells move away from the BMP source (Supplementary Fig 2h).
That the roof cells are equivalent to ﬂoor cells in their ability to
respond to BMP signalling was demonstrated by manipulating
the BMP pathway using FGF inhibition, which resulted in dorsal
extension of the BMP signalling domain accompanied by dorsal
expression of Runx1 in the DA60. A previous study described a
sub-population of venous-fated angioblasts in the DA61, thus
increasing the cellular complexity61. However, since we never
observed Citrine+ cells in the vein we suggest that these are
different from HE-forming angioblasts.
Together with manipulation, both up and down, of the Notch
pathway30,31,44, these data point the way towards the successful
differentiation of PSCs into HSCs. We propose that it will be
crucial to ﬁrst identify conditions that speciﬁcally generate
endothelial cells of the aortic lineage of the trunk region52
before inducing the differentiation into HE-like cells in vitro.
Importantly, similar observations have been made in a human
PSC differentiation culture, strongly supporting our in vivo
data62.
Despite its crucial role in HSC formation, how RUNX1 pro-
motes haematopoietic cell fate is still unclear18,20. Here, we have
identiﬁed a diverse set of potential target genes. Their respective
roles in DNA methylation, signalling and niche interaction begin
to reveal the mechanisms by which Runx1 transforms arterial
endothelial cells into fully functional HSCs. The ﬁnding that
expression of ﬁve zebraﬁsh Dnmt3 isoforms was substantially
reduced in runx1−/− mutants highlights the importance of DNA
de novo methylation for haematopoiesis63 and expands on indi-
cations that RUNX1 partly acts through global reorganization of
the epigenetic state20,64. DNA methylation could be stabilizing
the haematopoietic programme as shown for the Dnmt3bb.1-
dependent maintenance of cmyb expression29. Conversely, DNA
methylation may permanently silence the endothelial programme
that is initially repressed by GFI1/GFI1b and LSD1 function65.
Recruitment of DNMT3a by LSD1 has been described66.
Irf1b is a member of the inﬂammatory signalling pathway,
recently discovered to be critical for deﬁnitive
haematopoiesis34,47. In irf1b we have identiﬁed the ﬁrst inﬂam-
matory gene to be downstream of Runx1 activity, the marker used
for monitoring inﬂammatory input into HSC development. The
interaction however might be indirect since runx1−/− mutants
have fewer primitive neutrophils39, which are the source of pro-
inﬂammatory signals47.
The Runx1 target, Pik3cd, is a member of the mTOR pathway
and directly regulated by Runx1 in acute megakaryocytic leu-
kaemia cells67. PI3K activity is antagonized by PTEN, which in
zebraﬁsh was shown to prevent hyperproliferation of HSPCs in
the CHT68. Regulation of Pik3cd by RUNX1 might therefore be
involved in ﬁne-tuning the cell cycle of future HSCs.
Additional Runx1 targets identiﬁed here, such as angpt1 and
mpl, are haematopoietic niche interaction factors41–43,69. Of note,
Mpl−/− mutant mouse embryos show an impaired survival/self-
renewal of HSCs during their passage to the foetal liver70. It
appears that RUNX1 equips the HSC with the required hardware
for proper niche interaction.
Overall, we have shown that HSC-generating HE derives from
aortic endothelium whose subsequent differentiation into HSPCs
is dependent on the action of Runx1. We have further shown that
Runx1 drives repression of the arterial endothelial programme,
regulates transcription of epigenetic regulators that might be
Fig. 6 Aortic HE maintains arterial features in the absence of runx1. a qRT-PCR gene expression analysis of the arterial marker efnb2a and the venous
marker ephb4b in the HE and ARE of runx1+/+ (WT) and the HE of runx1−/− mutant (MUT) embryos. Graphs show the mean of detected expression levels
relative to the geometric mean (GM) of the two housekeeping genes eef1a1l and rpl13a. n= 5 independent biological experiments for WT embryos and n=
6 independent biological experiments for MUT embryos. Error bars represent the SEM. Two-way ANOVA; *p < 0.05; **p < 0.01; ***p < 0.001. b Heatmaps
of whole-genome gene expression data from RNA-seq for the HE of control and runx1 MO embryos showing arterial and venous genes. c Representative
ﬂuorescent microscopy image of 6 dpf TgBAC(runx1P2:Citrine), Tg(kdrl:mCherry) double transgenic embryos on a runx1+/+ or runx1−/− genetic background.
Left: Region depicting the region of deﬁnitive haematopoietic niches including the thymus (Th) and the kidney (Ki). Right: region depicting the DA and the
beginning of the caudal haematopoietic tissue (CHT). Green arrows point to the ventral wall of the DA. d Quantiﬁcation of embryos derived from the
indicated in-crosses (InX) depicting the runx1−/− mutant phenotype as depicted in (c). e ISH analysis of runx1 in control and dll4 MO embryos. Experiment
was performed with two different MOs. Green arrows point to the HE. f Offspring of dll4+/− heterozygous ﬁsh were analysed by ISH for runx1 at 32 hpf.
Runx1 expression was quantiﬁed by image analysis and subsequent genotyping57. Representative examples of runx1 expression in each of the WT, dll4+/−
and dll4−/− genotypes are shown in the right-hand panels and the corresponding expression values are shown as orange points in the graph. (μwt= 33.3,
μmut= 15.19, p < 0.0001, F(2,50)= 16,79, one way ANOVA). g Model depicting the lineage relationship between the deﬁnitive HE giving rise to HSCs and
arterial endothelium in the DA during embryogenesis. Dll4+ aortic progenitors get exposed to localised signals patterning the DA and inducing haemogenic
gene expression. Haemogenic speciﬁcation includes upregulation of runx1 expression and a subsequent Runx1 induced repression of dll4, thus giving rise to
Dll4− mature HE
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involved in stabilising this fate switch and sets up the HSC pro-
gramme including its niche-interaction capacity.
Methods
Zebraﬁsh lines and maintenance. Wild-type, Tg(kdrl:Hsa.HRAS-mCherry)71
(here called Tg(kdrl:mCherry)), dll4sa9436 mutants72 (here called dll4+/−) and
runx1W84X mutants39 (here called runx1+/− and runx1−/−) were bred, maintained
and staged as described22. All zebraﬁsh work was approved by the Research Ethics
Committee of the University of Oxford.
dll4sa9436 mutants were genotyped using a custom KASP Assay (LGC
Genomics) targeting the sequence CGGCCACTACACCTGCAACCCAGATGGCC
RGTTATCCTGTCTCCCTGGCT[G/A]GAAGGGGGAATACTGCGAAGAACGT
AAGCAATCAGAGWTCACAATTTATT, following the manufacturer’s
instructions. The TgBAC(runx1P2:Citrine) transgenic reporter was generated in the
KCL background. TgBAC(runx1P2:Citrine);Tg(kdrl:mCherry) double transgenic,
TgBAC(runx1P2:Citrine);runx1−/− and Tg(kdrl:mCherry);runx1−/− animals were
generated by natural mating. Mutant embryos were identiﬁed by genotyping ﬁn-
clipped 3.5 dpf embryos. DNA was extracted using the HotSHOT method73, PCR
performed using W84X genotyping primers (Supplementary Data 5) and
diagnostic gels were run after HaeII digest.
Morpholino and DNA injections. Antisense MOs (GeneTools) were used to target
runx122, gata2b23, tal1b74 cldn5b and dll4 (MO-175 and MO-276) at the amounts
indicated (Supplementary Data 5). Typically, 0.5–1 nl total volume of MO was
injected in 1–2 cell stage embryos. For rescue experiments, full length Runx1 was
ampliﬁed from cDNA of 28 hpf embryos and a ﬂag-tag added to the 5′ end. This
fragment was cloned downstream of the Ef1alpha promoter and a Rabbit β1-globin
intron B type 2 allele (accession number J00660 (552–1196)) and upstream of a
SV40 polyA sequence, ﬂanked by miniTOL2 sites. Fifty picograms of plasmid DNA
was injected with 25 pg transposase mRNA for the runx1 overexpression
experiment.
BAC cloning and transgenesis. BAC recombineering was based on the Suster
et al. protocol77 with the following alterations. The Citrine-SV40pAFKF (containing
kanamycin ﬂanked by two FRT sites, a kind gift from Prof. Tatjana Sauka-Spen-
gler) transgene cassette was introduced before the iTol2-amp cassette. BAC
recombineering was performed in SW105 cells. Ampliﬁcation of the homology-
constructs with 50 bp overhangs was performed with speciﬁc primers (Supple-
mentary Data 5). Recombineered BACs were puriﬁed using the Invitrogen Pure-
Link HiPure Plasmid Midiprep Kit (cat no K2100–04). Embryos were injected with
1 nl of DNA (180 ng/μl) plus tol2 mRNA (120 ng/μl) into the cell of early 1-cell
stage embryos.
Whole mount ISH. Whole-mount in situ hybridization was carried out as
described22. cDNA templates for in situ hybridization probes were generated by
PCR ampliﬁcation from 20–28 hpf embryo cDNA (see Supplementary Data 5 for
primers) and cloned into pGEMT-Easy. Probes for kdrl, runx1, cmyb and dll4 are
described elsewhere16,28,46,78. Analysis and quantiﬁcation of runx1 gene expression
after in situ hybridization in dll4 mutants was performed blinded. Brieﬂy, we
imaged all embryos from a dll4+/− incross, inverted and converted the images to 8-
bit grayscale. Next, we measured pixel intensity in an ROI containing the runx1
staining against an equivalent unstained background ROI to obtain a pixel intensity
value for each embryo79. After genotyping using the recommended KASP assay
(LGC Genomics) primers for the dll4 mutation72 following the manufacturer’s
instructions, pixel intensity values were assigned to each image and grouped
according to genotype. The mean intensity values were plotted in a dot plot and
analysis of the differences between genotypes was performed (Graphpad 8.0 soft-
ware, one way ANOVA).
FISH and immunohistochemistry. Double ﬂuorescent in situ hybridization was
performed as previously described80. Brieﬂy, embryos were incubated at 65 °C for
18 h in 2 ng/μl DIG- and ﬂuorescein-labelled mRNA probes runx1, Citrine (GFP)
and dll4. After washes, the embryos were sequentially incubated with horseradish
peroxidase-conjugated anti-FLUO (1:500; Roche) and anti-DIG (1:500; Roche)
antibodies. The RNA probes were sequentially developed with custom-made FLUO
(FITC; 1:200) and tetramethylrhodamine (TAMRA; 1:100) conjugated tyramide in
PBST containing 0.003% (v/v) H2O2 for 35 min at RT.
For FISH combined with immunohistochemistry ﬁrst FISH was performed
according to the standard in situ hybridisation protocol. The signal was developed
with SIGMAFAST Fast Red TR/Naphtol. Embryos were rinsed in phosphate-
buffered saline with Tween20 (PBT) and directly processed for
immunohistochemistry. Embryos were blocked in blocking buffer (5% goat serum/
0.3% Triton X-100 in PBT) for 1 h at RT before incubated with primary antibody
against GFP (rabbit, 1:500, Molecular Probes), diluted in blocking buffer overnight
at 4 °C. Secondary antibody raised in goat coupled to AlexaFluor488 (Invitrogen)
was used in 1:500 dilutions for 3 h at RT. Hoechst 33342 was used as a nuclear
counterstain.
Fluorescent images were taken on a Zeiss LSM880 confocal microscope using
10× air, 40× oil or 63× oil immersion objectives. Images were processed using the
ZEN software (Zeiss) to generate maximum intensity projections.
Wide-ﬁeld ﬂuorescence and live confocal microscopy. For wide-ﬁeld ﬂuores-
cence microscopy live embryos were anaesthetised with 160 μg/ml MS222 and
mounted in 3% methylcellulose. Embryos were assessed and imaged on a SteREO
Lumar V12 microscope (Zeiss) with an AxioCam MRm (Zeiss) or on a
MVX10 stereo microscope (Olympus) with an ORCA-Flash4.0 LT Digital CMOS
camera. Image acquisition and analysis was conducted with the AxioVision soft-
ware (Zeiss).
For live confocal microscopy embryos were grown in E3 medium supplemented
with PTU to prevent pigment cell formation. For imaging, embryos were
anaesthetised with 160 μg/ml MS222 and orientated at the bottom of 35 mm glass
bottomed dishes in 1% low melt agarose. Embryos were covered with E3 media
containing MS222 and imaged on an LSM780 or 880 confocal (Zeiss) at 28.5 °C.
Images were processed using the ZEN software (Zeiss) to generate maximum
intensity projections.
Cell dissociation and ﬂuorescent activated cell sorting. Embryos were staged
accordingly, pre-sorted for the presence of ﬂuorescent reporters using the Olympus
stereo microscope MVX10 and collected in low binding microcentrifuge tubes
(SafeSeal Microcentriguge Tubes, Sorenson; Cat#39640T). Yolk was removed using
116 mM NaCl/2.9 mM KCl/5 mM HEPES (with freshly added 1 mM EDTA)
deyolking buffer. Cells were dissociated using collagenase/trypsin buffer (20 mg
collagenase in 0.05% Trypsin with EDTA in 1× HBSS solution). Reaction was
stopped in 1× HBSS/10 mM HEPES/0.25% BSA. Dissociated cells were passed
through a 40 μm cell strainer and re-suspended in appropriated volume (~10 μl per
embryo; ~3–7 × 106 cells per ml) of 1× HBSS/10 mM HEPES/0.25% BSA with
HoechstDEAD (33258; Invitrogen) (1:4000 dilution). FAC-sorting was carried out
by the WIMM Flow Cytometry Facility using the BD FACS Aria Fusion system. To
identify the gating strategy for the DP-cells, we split the DP-gate into three sub-
gates of similar height in order to select for a DP-R1hi population with best
enrichment of haemogenic marker genes. Cells were either directly sorted into RLT
buffer (RNA isolation) or into 1× HBSS/10 mM HEPES/0.25% BSA buffer for
subsequent preparation of ATAC-seq libraries.
RNA extraction from FAC-sorted cells. To isolate RNA for qRT-PCR or RNA-
sequencing, cells were sorted into 350 μl RLT buffer (QIAGEN) containing 20 μl β-
mercaptoethanol per 1 ml RLT buffer and adjusted to a volume of 450 μl with RNA
free H2O (each sorted cell equals a volume of ~0.00325 μl). The cell lysate was
thoroughly vortexed and run through a QIAshredder (QIAGEN) column. RNA
was cleaned up using the RNeasy Plus Micro Kit (QIAGEN) according to manu-
facturer’s protocol. RNA was eluted twice with 10 μl of RNA free H2O. RNA
quality and quantity was determined using the 2100 Bioanalyzer Pico kit (Agilent
technologies).
qRT-PCR. cDNA was synthesized from total RNA (2–5 ng) using a SuperScript IV
(ThermoFisher) enzyme according to manufacturer’s instructions in a total volume
of 20 µl using random hexamer primers (250 ng) and 10 mM dNTPs. qRT-PCR
was performed on a 7500 real-time cycler (Applied Biosystems) using SYBR Green
(Fast SYBR Green; Applied Biosystems). Experiments were carried out in technical
duplicates with four individual biological replicates. qRT-PCR primers are listed
in Supplementary Data 5. Fold changes in gene expression were calculated using
the 2−ΔΔCτ method and normalized to a geometric mean of two housekeeping
genes,ubc and eef1a1l1.
Multiplexed gene expression analysis. Multiplex qRT–PCR was performed
using the Fluidigm (BioMark) platform. TaqMan probes (ThermoFischer) (see
Supplementary Data 5) were pooled to a concentration of 0.2×. Before cell sorting,
an RT-PreAmp master mix (consisting of 5 µl 2× Reaction Buffer and 1.2 µl
RT/Taq enzyme (ThermoFischer SuperScript III One-Step RT-PCR System with
Platinum Taq kit), 0.1 µl SUPERase-In RNAse Inhibitor (Ambion), 1.2 µl TE buffer
(Invitrogen), and 2.5 µl of 0.2× TaqMan assay mix) was freshly prepared on the
day. All pipetting steps were performed in a clean-room.
Hundred cells were directly sorted by FACS into 10 µl of RT-PreAmp master
mix. Collected samples were immediately vortexed and spun to aid cell lysis. RT-
PCR (15 min at 50 °C; 2 min at 95 °C) and pre-ampliﬁcation (15 s at 95 °C and
4 min at 60 °C; 20 cycles) was performed in a PCR machine and diluted with 40 µl
TE buffer. The pre-ampliﬁed mix was immediately frozen at −20 °C until further
analysis. Gene expression analysis was performed using a 48.48 IFC chip
(Fluidigm) according to the manufacturer’s instructions. Ct thresholds were set for
each assay with the same thresholds used across all experiments. Ct values were
calculated by BioMark Real-time PCR Analysis software (Fluidigm). Data were
exported to Excel as.csv ﬁles for subsequent analysis.
RNA sequencing analysis. At least 300 TgBAC(runx1P2:Citrine);Tg(kdrl:
mCherry) double transgenic embryos for both runx1 MO and wild-type conditions
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were processed for RNA isolation from speciﬁc cell populations after FAC-sorting.
To control for batch effects potentially derived from different clutches, every clutch
of embryos was split in half, whereby one half remained un-manipulated and the
other was injected with runx1 MO. Injected and non-injected embryos were pooled
accordingly and staged to 28–30 hpf for subsequent FAC-sorting. RNA-seq library
generation (SMARTer libraries for low-input RNA) and sequencing (Illumina
HiSeq4000 with 75 bp paired end) was performed by the Welcome Trust Centre for
Human Genetics (WTCHG) using 2.2 ng of total RNA. ~24–30 million reads per
sample were generated.
Sequenced reads were checked for base quality, trimmed where 20% of the bases
were below quality score 20, and ﬁltered to exclude adapters using Trimmomatic
(Version 0.32). Sequences were aligned to the Zebraﬁsh Genome Zv10 with STAR
with default parameters. Aligned read features were counted using Subread tool:
featureCounts method (version 1.4.5-p1). Differential gene expression (DEG)
analysis was carried out using EdgR (Bioconductor Package).
To determine number of mapped reads we used the trimmed data. The
alignment has been performed using STAR with default parameters. The number
of mapped reads (QC-passed reads count) has been obtain using Samtools
mapping statistics (ﬂagstat tool).
For ANOVA-like test analysis, the generalized linear model (GLM) analysis was
used as followed: Estimates “Dispersion”, ﬁtted with “negative binomial model”
and estimates “Generalized linear model likelihood ratio”. Genes with a False
Discovery Rate (FDR) less than 0.05 were ﬁltered out. Further, genes were ﬁltered
for log2 Fold Change <−0.7 and >0.7. Reads per kilobase per million (RPKM)
values were used as input for Clustering analysis. A z-score transformation of the
log2 replicates mean for each sample was performed. Clustering analysis was
performed using the Consensus Clustering Plus algorithm81 with maximum cluster
number to evaluate equal to 15. The algorithm generated a CDF plot assessing
number of eight clusters as best stability. Using the genes of each cluster, heat-maps
were generated using the z-score values.
To identify genes that were differentially expressed between two populations,
we used GLM analysis. For the DP-R1lo vs. DP-R1hi DEG analysis all endothelial
populations (SP-kdrl, DP-R1lo, DP-R1med and DP-R1hi) were included into
ANOVA-like test analysis. For the control embryo vs. MO embryo DEG analysis
(for both DN and DP-R1hi) all four populations (DN-Wt, DN-MO, DP-R1hi-Wt
and DP-R1hi-MO) were included into ANOVA-like test analysis. After
normalization all genes with less than three samples with read counts >0 were
removed prior to DEG analysis. All genes with a FDR value >0.05 or with at least
three samples equal to 0 read counts were removed from further analysis.
Enrichment of GO terms and KEGG pathways were calculated with DAVID6.8.
Representative GO terms were taken from the BP_DIRECT class.
ATAC-sequencing analysis. For genome wide open chromatin analysis by
ATAC-seq, 2000–3000 cells were FAC-sorted directly into 100 µl of 1× HBSS/10
mM HEPES/0.25% BSA buffer and spun down at 500 g for 5 min at 4 °C. Tag-
mentation was performed as described82, but with 1.5 µl Tn5 transposase (Illu-
mina) in a 50 µl reaction volume. Immediately after transposition, DNA was
puriﬁed using the QIAquick PCR puriﬁcation kit (Qiagen), eluted 2× with 10 µl EB
buffer and stored at −20 °C. Eighteen microlitres of transposed DNA was taken
forward into a 50 µl PCR reaction mix with barcoded primers and 25 µl of 2×
NEBNext High-Fidelity 2× PCR Master Mix (NEB). Fragments were ampliﬁed for
16 cycles.
As a genomic DNA control, DNA from 30,000 cells was isolated using the
DNeasy Blood & Tissue kit (Qiagen) and eluted with 25 µl EB buffer. Tagmentation
was performed as described. Fragments were ampliﬁed for nine cycles. Fragment
sizes were veriﬁed using Tapestation (Agilent) and libraries were quantiﬁed using
KAPA Library Quant Kit for Illumina Sequencing Platforms (KAPABiosystems).
Sequencing was performed on a NextSeq machine.
Sequenced reads were checked for base qualities, trimmed where 20% of the
bases were below quality score 20, and ﬁltered to exclude adapters using
Trimmomatic (Version 0.32). Sequences were aligned to the Zebraﬁsh Genome
Zv10 with BWA (Version 0.7.12) with default parameters. Aligned read features
were counted using Subread tool: featureCounts method (version 1.4.5-p1). Peaks
were identiﬁed using MAC2 software (Version 1.4.2), using the genomic DNA as
input to deﬁne background. Differential peaks analysis was carried out using
DiffBind (Bioconductor Package). Triplicates were analysed for consistency by
PCA and correlation analysis and one outlying replicate has been removed for
each, DP-R1hi and DP-R1lo. Using a GLM analysis with EdgeR methods a list of
DE packs between DP-R1hi and DP-R1lo population has been identiﬁed, then
annotated with Homer software (Version 3.0). Further, peaks were ﬁltered for log2
Fold Change <−0.7 and >0.7. Selecting the speciﬁc peaks for DP-R1hi and DP-
R1lo. “De novo analysis” for transcription factor binding site has been carried out
using the TSS, intergenic, and intron peaks list with “ﬁndMotifsGenome.pl” in
Homer software package.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data generated or analysed during this study are included in this published article
(and its supplementary information ﬁles). Accession codes for RNAseq and ATACseq
have been deposited in the GEO database under accession codes: GSE132259 and
GSE132258, respectively.
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